EMBC
Embecta Corp. · Healthcare · Medical - Instruments & Supplies
动量输入(同类管理人):
持有人广度 +5.9% ·
股份流向 -1.0% ·
净新建仓位 +5.6%
· 公式
持有人分散化:持有人数增多,合计持仓比例缩小。
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 41.07K | $236,163 | n/a | n/a |
| Q2 2026 | 82 | -4 | 27.59M | $90.42M | +11 | −16 |
| Q1 2026 | 90 | -9 | 35.88M | $317.56M | +2 | −11 |
| Q4 2025 | 98 | +3 | 38.68M | $459.60M | +3 | n/a |
| Q3 2025 | 18 | +1 | 23.51M | $331.78M | +3 | −2 |
| Q2 2025 | 14 | +1 | 21.26M | $206.03M | +3 | −2 |
| Q1 2025 | 10 | -1 | 6.04M | $76.89M | n/a | −1 |
| Q4 2024 | 11 | -1 | 6.48M | $133.73M | n/a | −1 |
| Q3 2024 | 11 | +1 | 5.91M | $83.38M | +2 | −1 |
| Q2 2024 | 10 | n/a | 7.60M | $94.96M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 8.79M | -0.9% | $124.07M | 0.0% | ▼ Trim | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (被动) | 5.46M | 0.0% | $77.10M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 2.33M | -2.9% | $32.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.44M | -21.3% | $20.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.43M | -5.6% | $20.15M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 904.41K | n/a | $12.76M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 7 | JPMorgan Chase ✦ | 869.64K | n/a | $12.27M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 8 | Goldman Sachs Group ✦ | 716.16K | n/a | $10.10M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 564.24K | -8.8% | $7.96M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Arrowstreet Capital ✦ | 251.37K | 新增 | $3.55M | 0.0% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 221.20K | 新增 | $3.12M | 0.0% | New | 1 | SEC ↗ ×3 |
| 12 | AQR Capital Management ✦ | 217.45K | +6.4% | $3.06M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | Citadel Advisors ✦ | 86.30K | -15.3% | $1.22M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 75.01K | 新增 | $1.06M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 68.08K | +4.5% | $961,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 41.47K | -1.2% | $585,128 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Tweedy, Browne ✦ | 41.28K | +105.4% | $582,447 | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 7.05K | +16.4% | $99,423 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $3.55M | 0.0% |
| Wellington Management | $3.12M | 0.0% |
| Gotham Asset Management | $1.06M | 0.0% |
已清仓
| Point72 Asset Management | $741,285 | 曾为 0.0% |
| Marshall Wace | $483,278 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 335 持有人, 60.19M 股份, $506.91M 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
Officer · SVP and CFO · 20.00K 股 @ 4.67 · $93,360
Director · 45.00K 股 @ 4.97 · $223,848
Officer · Pres, Pharm Svc&Prod… · 20.00K 股 @ 4.99 · $99,800
Officer, Director · President and CEO · 30.00K 股 @ 4.70 · $140,937
公开市场卖出 (S)
Director · 6.29K 股 · $36,971
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论